openPR Logo
Press release

The Global Heparin market is expected to grow at a CAGR of 6.4% as the world moves towards better technology to prevent blood clotting

06-20-2019 11:29 AM CET | Health & Medicine

Press release from: DataM Intelligence

The Global Heparin market is expected to grow at a CAGR of 6.4% as

Hyderabad, June 20, 2019 -- The "Heparin Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2026" report has been added to Datamintelligence.com's offering.

With approximately 500 million doses of heparin being used worldwide every year, the annual market for Heparin was valued at USD 10 billion in 2017.

Click here to get your copy of free sample https://www.datamintelligence.com/research-report/heparin-market

Heparin Market Trends : Drivers and Restraints
The market has significant growth opportunities owing to growing potential applications of heparin ranging from anti-inflammatory and anti-tumor applications to prevention of infectious disease and use as nano-carriers for drug delivery.
Also, the rising number of coagulation disorders such as venous thromboembolism (VTE) will also fuel market growth.
However, the wide availability of alternative anticoagulants such as warfarin, coumarins, and oral anticoagulants are expected to hamper heparin sales, thereby negatively impacting market growth.

Heparin Market Segmentation:
By Product Type
⦁Unfractioned Heparin (UFH)
⦁Low Molecular Weight Heparin (LMWH)
⦁Ultra-Low Molecular Weight Heparin (ULMWH)
By Source Type
⦁Bovine
⦁Porcine
By Formulation Type
⦁Oral
⦁Parenteral
By Region
⦁Asia Pacific (China, Japan, India, Australia, Rest of Asia Pacific)
⦁Europe (Germany, France, The UK, Italy, Spain, Rest of Europe)
⦁North America (The USA, Canada, Mexico)
⦁South America (Brazil, Argentina, Rest of South America)
⦁Rest of the World

Key Points covered in the report
⦁Heparin Market – Methodology and Scope
⦁Heparin Market - Trends
⦁Heparin Market – Industry Analysis
⦁Geographical Analysis
⦁Competitive Landscape
⦁Company Profiles

Heparin Market Key Companies
Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Fresenius SE & Co. KGaA, Sanofi, Pfizer, Inc., LEO Pharma A/S, Aspen, Baxter International Inc., B. Braun Melsungen AG, and Syntex S.A.
For more information about this report visit https://www.datamintelligence.com/research-report/heparin-market

DataM Intelligence also offers Custom Research services providing focused, comprehensive and tailored research.

About DataM Intelligence :
DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence. Reporting the actual market scenario has been made possible by our proprietary methodology, that essentially revolves around gathering inputs from industry participants and integrating the trends into statistical Databank. This approach not only aligns the findings with historic data but also allows a highly justifiable forecast model.
DMI is currently strengthening its cross-industrial database for sectors including Chemicals, Materials, Agriculture, Healthcare Services, Animal Nutrition, Consumer Goods, Food & Beverages, Industrial Machinery and Automation among others.

1st floor, Phoenix Tech Tower, Plo no: 14/46, Habsidguda, IDA-Uppal, Hyderabad-500039, Telangana.

DataM Intelligence 4Market Research is a Market Intelligence and Business Research firm, based in India. It aims to bridge the two main aspects of a business decision - opinion and supportive data.
Market Research for long has been losing its credibility owing to low reliability and high proportions of estimations. Having identified this gap, DataM was established to provide businesses with reliable and near-market intelligence.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Heparin market is expected to grow at a CAGR of 6.4% as the world moves towards better technology to prevent blood clotting here

News-ID: 1782351 • Views:

More Releases from DataM Intelligence

Food Supplement Market Poised to Surpass US$ 345.13 Billion by 2031 Driven by Aging Population
Food Supplement Market Poised to Surpass US$ 345.13 Billion by 2031 Driven by Ag …
According to DataM Intelligence, the Global Food Supplement Market reached US$ 203.10 billion in 2024 and is forecasted to reach US$ 345.13 billion by 2031, expanding at a CAGR of 8.4% during 2025-2031. The driving force behind this growth is the global rise in aging populations coupled with increasing awareness of preventive healthcare and healthy living. As individuals age, challenges such as weakened immunity, cognitive decline, joint pain, and bone-related
Biofuels Market Size to Reach US$ 252.19 Billion by 2032 Driven by Clean Energy Mandates
Biofuels Market Size to Reach US$ 252.19 Billion by 2032 Driven by Clean Energy …
The global biofuels market, valued at US$ 153.88 billion in 2024, is expected to reach US$ 252.19 billion by 2032, registering a compound annual growth rate (CAGR) of 6.4% between 2025 and 2032. Rising environmental concerns, greenhouse gas reduction targets, and global commitments toward clean energy are driving the shift toward biofuels as a sustainable replacement for fossil fuels. According to the World Bioenergy Association's 2024 Global Bioenergy Statistics Report, biofuels
Industrial Gases Market to Hit High Growth by 2031 Driven by Hydrogen & Semiconductor Demand
Industrial Gases Market to Hit High Growth by 2031 Driven by Hydrogen & Semicond …
The global industrial gases market is poised for steady growth over the forecast period, with a projected compound annual growth rate (CAGR) of 6.11% from 2024 to 2031. Depending on the source and forecast period, estimates range from 5% to 11%, underscoring a healthy upward trend. Key drivers include the expansion of the chemical, healthcare, and electronics sectors, ongoing industrialization in emerging economies, and the accelerating demand for hydrogen-particularly green
Hemostats Market Report Analysis, Research Studies | Lifesciences, Artivion, Medesy, World Precision Instruments
Hemostats Market Report Analysis, Research Studies | Lifesciences, Artivion, Med …
Global Hemostats Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031 A hemostat is a surgical instrument used to control bleeding by clamping shut exposed blood vessels. Resembling pliers or scissors, it features a locking mechanism with interlocking teeth that allows precise adjustment of clamping force. Hemostats are typically employed during the

All 5 Releases


More Releases for Heparin

Heparin (Heparin Sodium and Heparin Calcium) Market Size, Overview And Forecast …
"The Global Heparin (Heparin Sodium and Heparin Calcium) Market Size is projected to reach at a CAGR of 3.4% during 2024-2032." Global Heparin (Heparin Sodium and Heparin Calcium) market Size, Status, and Forecast for the 2024-2032. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Heparin (Heparin Sodium and Heparin Calcium) Market including
Heparin (Heparin Sodium and Heparin Calcium) Market explores demand trends, grow …
"𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬𝐞𝐬 𝐰𝐢𝐭𝐡 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐒𝐦𝐚𝐫𝐭𝐞𝐫 𝐃𝐞𝐜𝐢𝐬𝐢𝐨𝐧-𝐌𝐚𝐤𝐢𝐧𝐠" The global Heparin (Heparin Sodium and Heparin Calcium) market is anticipated to grow from USD 1,202 Million in 2023 to USD 1,509 Million by 2033, at a CAGR of 3.3 % during the forecast period. Heparin (Heparin Sodium and Heparin Calcium) 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐜𝐨𝐩𝐞, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟑 𝐫𝐞𝐩𝐨𝐫𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐢𝐧𝐜𝐥𝐮𝐝𝐞𝐝 𝐢𝐧 𝐄𝐱𝐚𝐜𝐭𝐢𝐭𝐮𝐝𝐞 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐚𝐧𝐜𝐲'𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐜𝐨𝐥𝐥𝐞𝐜𝐭𝐢𝐨𝐧. Heparin (Heparin Sodium and Heparin Calcium) Market
Heparin Market Report 2023 | Increasing the Advantages of Low Molecular Weight H …
According to Precision Business Insights (PBI), the latest report the global heparin market size was valued at USD 7,923.7 million in 2022 and is projected to grow at a 2.8% CAGR during the forecast period 2023 to 2029. The efficacy of these drugs as an anticoagulant is one of the key factors expected to drive global market growth. Furthermore, undeniable factors such as technological advancement and introducing of new products
Heparin Market
The heparin market refers to the global market for heparin, a blood-thinning medication that is commonly used in the prevention and treatment of blood clots. Heparin is typically derived from the mucous membranes of animals such as pigs and cows, and it is commonly used in a variety of medical settings, including hospitals, clinics, and home care settings. The heparin market has experienced steady growth over the past few years, driven
Global Heparin(Heparin Sodium and Heparin Calcium) Market drivers, restraints, g …
Latest industry research report on: Global Heparin(Heparin Sodium and Heparin Calcium) Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts This report studies the global Heparin(Heparin Sodium and Heparin Calcium) market status and forecast, categorizes the global Heparin(Heparin Sodium and Heparin Calcium) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China,
Heparin Market: Rapid Growth of Heparin Market Anticipated in Several European N …
Europe is among the major regions contributing to the global heparin market owing to its developed economy and high prevalence of coagulation disorders. According to the Ageing Report published by the European Commission in 2015, the percentage of population aged above 65 years is expected to increase from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the rising incidence of venous thromboembolism (VTE) diseases such as